NovaBay Pharmaceuticals, Inc.
NBY
$1.03
$0.4371.67%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.34M | 8.47M | 430.00K | 776.00K | 751.00K |
| Total Receivables | 51.00K | 312.00K | 389.00K | 704.00K | 547.00K |
| Inventory | 467.00K | -- | 765.00K | 498.00K | 700.00K |
| Prepaid Expenses | 108.00K | 115.00K | 193.00K | 185.00K | 161.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 145.00K | 144.00K | 158.00K | 116.00K | 94.00K |
| Total Current Assets | 6.12M | 9.04M | 1.94M | 2.28M | 2.25M |
|
|
|||||
| Total Current Assets | 6.12M | 9.04M | 1.94M | 2.28M | 2.25M |
| Net Property, Plant & Equipment | 317.00K | 355.00K | 1.01M | 1.10M | 1.20M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 479.00K | 479.00K | 480.00K | 495.00K | 476.00K |
| Total Assets | 6.91M | 9.87M | 3.42M | 3.88M | 3.93M |
|
|
|||||
| Total Accounts Payable | 604.00K | 800.00K | 623.00K | 396.00K | 1.24M |
| Total Accrued Expenses | 758.00K | 652.00K | 769.00K | 396.00K | 524.00K |
| Short-term Debt | 111.00K | 84.00K | 565.00K | 51.00K | 696.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 409.00K | 403.00K | 398.00K | 390.00K | 382.00K |
| Total Finance Division Other Current Liabilities | 262.00K | 1.13M | 488.00K | 751.00K | 773.00K |
| Total Other Current Liabilities | 262.00K | 1.13M | 488.00K | 751.00K | 773.00K |
| Total Current Liabilities | 2.14M | 3.07M | 2.84M | 1.98M | 3.61M |
|
|
|||||
| Total Current Liabilities | 2.14M | 3.07M | 2.84M | 1.98M | 3.61M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 111.00K | 84.00K | 565.00K | 51.00K | 696.00K |
| Capital Leases | 522.00K | 638.00K | 709.00K | 821.00K | 932.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.67M | 3.71M | 3.55M | 2.81M | 4.54M |
|
|
|||||
| Common Stock & APIC | 181.95M | 181.95M | 183.32M | 183.31M | 179.41M |
| Retained Earnings | -177.71M | -175.79M | -183.46M | -182.25M | -180.03M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.24M | 6.16M | -135.00K | 1.07M | -623.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K |
|
|
|||||
| Total Common Equity | 4.24M | 6.16M | -135.00K | 1.07M | -623.00K |
| Total Preferred Equity | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.25M | 6.17M | -129.00K | 1.07M | -617.00K |
|
|
|||||